title: The timing of administration, dose dependence and efficacy of dopa decarboxylase inhibitors on the reversal of motor disability produced by L-DOPA in the MPTP-treated common marmoset.
authors.affiliation: Neurodegenerative Diseases Research Centre, School of Health and Biomedical Sciences, King's College, London, UK.
authors.forename: Kayhan A
authors.initials: KA
authors.lastname: Tayarani-Binazir
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Jackson
authors.forename: Ria
authors.initials: R
authors.lastname: Fisher
authors.forename: Ghada
authors.initials: G
authors.lastname: Zoubiane
authors.forename: Sarah
authors.initials: S
authors.lastname: Rose
authors.forename: Peter
authors.initials: P
authors.lastname: Jenner
mesh_terms: D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000494:pharmacology*; D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001545:Benserazide / Q000008:administration & dosage / Q000494:pharmacology; D002144:Callithrix; D002230:Carbidopa / Q000008:administration & dosage / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004357:Drug Synergism; D004791:Enzyme Inhibitors / Q000008:administration & dosage* / Q000494:pharmacology*; D005260:Female; D007980:Levodopa / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D008750:Methyldopa / Q000008:administration & dosage / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D009069:Movement Disorders / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology
chemical_list: D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004791:Enzyme Inhibitors; D007980:Levodopa; D008750:Methyldopa; D001545:Benserazide; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D002230:Carbidopa